
Crh Medical (CRHM) Earnings Dates & Reports
Crh Medical (CRHM) Most Recent Earnings
Report Date
Period EndingQ2 2020
Est. EPS$0.04
Actual EPS-$0.04
EarningsMiss
Crh Medical (CRHM) Earnings
View the latest Crh Medical (CRHM) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Crh Medical (CRHM)
Order type
Buy in
Order amount
Est. shares
0 shares
Crh Medical (CRHM) Earnings per Share (EPS) History
Signup for full accessBrowse free
Crh Medical (CRHM) Latest Earnings
The value each CRHM share was expected to gain vs. the value each share gained.
Crh Medical (CRHM) reported its most recent earnings on for Q2 2020, posting earnings per share (EPS) of -$0.04. This exceeded analysts' expectations of $0.04 by 200.00%, marking a Miss.
For comparison, Crh Medical reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.04.
Crh Medical (CRHM) Earnings History
Crh Medical (CRHM) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Crh Medical’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Crh Medical (CRHM) Earnings FAQs
Crh Medical (CRHM) last reported earnings on Aug 10, 2020 for Q2 2020, posting an EPS of -$0.04, which Miss the estimate of $0.04 by 200.00%.
For Q2 2020, Crh Medical (CRHM) reported an EPS of -$0.04, missing analysts' estimate of $0.04 by 200.00%.
For Q2 2020, Crh Medical (CRHM) Miss expectations with an actual EPS of -$0.04 vs. an estimated EPS of $0.04.
Following the last earnings report on Aug 10, 2020, Crh Medical (CRHM)'s stock price moved — from — to —.
The next Crh Medical (CRHM) earnings call is scheduled for Mar. 16, 2021, where executives will discuss financial results and outlook.